leadf
logo-loader
viewMicrobix Biosystems Inc
(
TSX:MBX
)

Microbix Biosystems products 'gaining increasing success' with diagnostic manufacturers and clinical labs

Microbix Biosystems Inc (TSX:MBX). CEO Cameron (NYSE:CAM) Groome joined Proactive to discuss how the Mississauga, Onatario-based biotechnology group's suite of quality control for diagnostics products are 'gaining increasing success' for diagnostic manufactures and clinical laboratories.

Groome says many leading diagnostics companies have been citing or recommending Microbix's products for its users.

He adds the group is completing work on controls for the Delta variant of the coronavirus, with controls already in place for the original strain, the Brazilian, South African, and UK strain.

Quick facts: Microbix Biosystems Inc

Follow
TSX:MBX

Price: 0.58 CAD

Market Cap: $71.86 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Proactive Presents a Livestream Event with Nextech AR Solutions

Proactive's Steve Darling presents a Livestream Chat with NextTech AR Solutions Joining the chat Evan Gappelberg - CEO and Founder Paul Duffy - President and Chairman of the Board Mirjana Prpa - AR Product Manager and Head of AI Division Baran Korkmaz - Founder of ARway

2 hours, 33 minutes ago

2 min read